Evaluating ginkgetin from Ginkgo biloba as a novel agent for sleep promotion through molecular docking and in vivo studies.

IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Mir Behrad Aghazadeh Ghadim, Ebrahim Salimi-Sabour, Alireza Shahriari, Mahdi Niazi, Farideh Bahrami
{"title":"Evaluating ginkgetin from <i>Ginkgo biloba</i> as a novel agent for sleep promotion through molecular docking and <i>in vivo</i> studies.","authors":"Mir Behrad Aghazadeh Ghadim, Ebrahim Salimi-Sabour, Alireza Shahriari, Mahdi Niazi, Farideh Bahrami","doi":"10.22038/ijbms.2025.82718.17878","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Sleep impacts the well-being and quality of life of millions. Given conventional pharmacotherapy's limitations and side effects, the quest for adequate and proper sleep promotion is imperative. This study aims to identify a suitable and effective compound for sleep by examining qualified herbal compounds in the PubChem database using <i>in silico</i> methods. Ultimately, the extracted compound (ginkgetin, a bioactive flavonoid from <i>Ginkgo biloba</i>) through molecular docking by considering the GABAA receptors will be evaluated through the <i>in vivo</i> method in an animal model to serve as proof for the findings from the molecular docking process.</p><p><strong>Materials and methods: </strong>Utilizing a comprehensive approach, this research employed molecular docking to screen 2299 phytochemicals for their affinity towards the GABAA receptor, focusing on the GABA, benzodiazepine, and steroid-binding sites. Ginkgetin emerged as a top candidate due to its high binding affinity. Subsequent <i>in vivo</i> electrophysiological assessments in rats treated with <i>G. biloba</i> extract containing ginkgetin evaluated alterations in sleep architecture, REM, and NREM sleep phases.</p><p><strong>Results: </strong>Molecular docking identified ginkgetin as possessing the highest binding affinity among the screened phytochemicals. <i>In vivo</i> studies corroborated these findings, demonstrating that rats treated with <i>Ginkgo biloba</i> extract significantly enhanced REM and NREM sleep compared to controls.</p><p><strong>Conclusion: </strong>Ginkgetin, derived from <i>G. biloba</i>, shows promising potential as a novel therapeutic agent for sleep disorders, supported by its strong affinity to key receptor sites and its efficacy in modulating sleep architecture <i>in vivo</i>. These findings contribute to the expanding evidence base for the therapeutic use of <i>G. biloba</i> in sleep promotion and underscore the need for further research to elucidate the mechanisms and clinical applicability of ginkgetin in sleep disorder treatment.</p>","PeriodicalId":14495,"journal":{"name":"Iranian Journal of Basic Medical Sciences","volume":"28 6","pages":"746-754"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057750/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Basic Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.22038/ijbms.2025.82718.17878","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Sleep impacts the well-being and quality of life of millions. Given conventional pharmacotherapy's limitations and side effects, the quest for adequate and proper sleep promotion is imperative. This study aims to identify a suitable and effective compound for sleep by examining qualified herbal compounds in the PubChem database using in silico methods. Ultimately, the extracted compound (ginkgetin, a bioactive flavonoid from Ginkgo biloba) through molecular docking by considering the GABAA receptors will be evaluated through the in vivo method in an animal model to serve as proof for the findings from the molecular docking process.

Materials and methods: Utilizing a comprehensive approach, this research employed molecular docking to screen 2299 phytochemicals for their affinity towards the GABAA receptor, focusing on the GABA, benzodiazepine, and steroid-binding sites. Ginkgetin emerged as a top candidate due to its high binding affinity. Subsequent in vivo electrophysiological assessments in rats treated with G. biloba extract containing ginkgetin evaluated alterations in sleep architecture, REM, and NREM sleep phases.

Results: Molecular docking identified ginkgetin as possessing the highest binding affinity among the screened phytochemicals. In vivo studies corroborated these findings, demonstrating that rats treated with Ginkgo biloba extract significantly enhanced REM and NREM sleep compared to controls.

Conclusion: Ginkgetin, derived from G. biloba, shows promising potential as a novel therapeutic agent for sleep disorders, supported by its strong affinity to key receptor sites and its efficacy in modulating sleep architecture in vivo. These findings contribute to the expanding evidence base for the therapeutic use of G. biloba in sleep promotion and underscore the need for further research to elucidate the mechanisms and clinical applicability of ginkgetin in sleep disorder treatment.

通过分子对接和体内研究评价银杏叶中的银杏素作为促进睡眠的新药物。
目的:睡眠影响数百万人的健康和生活质量。鉴于传统药物疗法的局限性和副作用,寻求充足和适当的睡眠促进是势在必行的。本研究旨在通过使用计算机方法检查PubChem数据库中合格的草药化合物,以确定一种合适且有效的睡眠化合物。最终,通过考虑GABAA受体的分子对接提取的化合物(银杏黄酮)将在动物模型中通过体内方法进行评估,为分子对接过程的发现提供证据。材料与方法:本研究采用分子对接的方法,综合筛选2299种植物化学物质对GABAA受体的亲和力,重点筛选GABA、苯二氮卓类和类固醇结合位点。银杏苷因其高结合亲和力而成为首选。随后用含银杏素的银杏叶提取物治疗的大鼠体内电生理评估评估了睡眠结构、快速眼动和非快速眼动睡眠期的变化。结果:分子对接发现银杏苷在筛选的植物化学物质中具有最高的结合亲和力。体内研究证实了这些发现,表明与对照组相比,用银杏叶提取物治疗的大鼠显著增强了快速眼动和非快速眼动睡眠。结论:从银杏中提取的银杏苷具有与关键受体位点的强亲和力和调节体内睡眠结构的功效,有望成为一种治疗睡眠障碍的新型药物。这些发现为银杏促进睡眠的临床应用提供了进一步的证据基础,同时也表明银杏素治疗睡眠障碍的机制和临床适用性有待进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Iranian Journal of Basic Medical Sciences
Iranian Journal of Basic Medical Sciences MEDICINE, RESEARCH & EXPERIMENTAL-PHARMACOLOGY & PHARMACY
CiteScore
4.00
自引率
4.50%
发文量
142
审稿时长
6-12 weeks
期刊介绍: The Iranian Journal of Basic Medical Sciences (IJBMS) is a peer-reviewed, monthly publication by Mashhad University of Medical Sciences (MUMS), Mashhad, Iran . The Journal of "IJBMS” is a modern forum for scientific communication. Data and information, useful to investigators in any discipline in basic medical sciences mainly including Anatomical Sciences, Biochemistry, Genetics, Immunology, Microbiology, Pathology, Pharmacology, Pharmaceutical Sciences, and Physiology, will be published after they have been peer reviewed. This will also include reviews and multidisciplinary research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信